Dr. Manasi Shah

MBBS, MD (Internal Medicine), MD (Medical Oncology)


Contact info

OPD Appointments

  • Mon - Fri
  • Sat
  • Sun
  • 9:00 am - 6:00 pm
  • 9:00 am - 6:00 pm
  • Closed


  • MBBS (1999-2005) - Smt. NHL Municipal Medical College.
  • Internal Medicine (2006-2009) - Bridgeport Hospital, Yale University School of Medicine, USA.
  • Fellowship in Hematology and Medical Oncology (2009-2012)- University of Connecticut, USA.


Dr. Manasi Shah graduated from University of Connecticut where she also served as a Clinical Assistant Professor. She then moved on to NewYork - Presbyterian Medical Group Westchester, NY (Lawrence Medical Associates) as an attending in Medical Oncology and Hematology where she took care of patients from 2012-2015. She decided to move back to her hometown, Ahmedabad and is currently working as a consultant in Medical Oncology at HCG Cancer Center, Ahmedabad.


She has an experties in treatment of solid tumors with a special focus in Breast and Gynecologic Malignancies, Cancer Genomics, Chemotherapy, Targeted Therapy, Hormone Therapy and Immunotherapy.

Research / Publications

Research Grant

  • Awarded in 2011 by the Connecticut Health Breast Initiative for the research project - Impact of HER2 on the outcomes of patients with small breast cancers.
Published Manuscripts

  • Transoral robotic surgery in management of oropharyngeal cancers: a preliminary experience at a tertiary cancer centre in India. International journal of clinical oncology. 2015 Aug 1;20(4):693-700
  • Saif MW, Shah M., K-ras mutations in colorectal cancer: a practice changing discovery, Clin Adv Hematol Oncol. 2009 Jan;7(1):45-64.
  • Saif MW, Shah M, Shah A, Fluoropyrimidine associated cardiotoxicity: revisited, Expert Opinion in Drug Safety, 2009 March: 8 (2): 191-202.
  • Shah M, Summerhill E, Manthous CA, Medical Professionalism in the New Millennium: Are there intercultural differences?, Conn Med. 2009 May;73(5):289-94.
  • Shah M, Saif MW, Pancreatic Cancer and Thrombosis: Highlights from the “2010 ASCO Annual Meeting”. J Pancreas (Online) 2010 Jul YY; 11(4):331-333.

  • Lindner R, Offor O, Chaves J, Fischbach N, Shah M, Activation of the Insulin-Like Growth Factor Pathway distinguishes African American from European American patients with triple-negative breast cancer by Gene Expression Profiling, Annual San Antonio Breast cancer Symposium, December 2009.
  • Shah M, Fischbach N, Outcomes of triple negative breast cancer in African- Americans vs. Caucasians: a community based study, Annual San Antonio Breast Cancer Symposium, December 2008.

Book your appointment

We will confirm your appointment within 2 hours

Emergency Call

+91 9979260999